Literature DB >> 19448654

Hybrid Treg cells: steel frames and plastic exteriors.

Michael J Barnes1, Fiona Powrie.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19448654     DOI： 10.1038/ni0609-563

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  18 in total

1.  The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Authors:  Anne Brüstle; Sylvia Heink; Magdalena Huber; Christine Rosenplänter; Christine Stadelmann; Philipp Yu; Enrico Arpaia; Tak W Mak; Thomas Kamradt; Michael Lohoff
Journal:  Nat Immunol       Date:  2007-08-05       Impact factor: 25.606

2.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

3.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

4.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

5.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

6.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

7.  Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.

Authors:  Ye Zheng; Ashutosh Chaudhry; Arnold Kas; Paul deRoos; Jeong M Kim; Tin-Tin Chu; Lynn Corcoran; Piper Treuting; Ulf Klein; Alexander Y Rudensky
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

8.  Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells.

Authors:  Jochen Huehn; Kerstin Siegmund; Joachim C U Lehmann; Christiane Siewert; Uta Haubold; Markus Feuerer; Gudrun F Debes; Joerg Lauber; Oliver Frey; Grzegorz K Przybylski; Uwe Niesner; Maurus de la Rosa; Christian A Schmidt; Rolf Bräuer; Jan Buer; Alexander Scheffold; Alf Hamann
Journal:  J Exp Med       Date:  2004-02-02       Impact factor: 14.307

9.  GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells.

Authors:  Pierre-Yves Mantel; Harmjan Kuipers; Onur Boyman; Claudio Rhyner; Nadia Ouaked; Beate Rückert; Christian Karagiannidis; Bart N Lambrecht; Rudolf W Hendriks; Reto Crameri; Cezmi A Akdis; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  PLoS Biol       Date:  2007-12       Impact factor: 8.029

10.  Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease.

Authors:  Blythe D Sather; Piper Treuting; Nikole Perdue; Mike Miazgowicz; Jason D Fontenot; Alexander Y Rudensky; Daniel J Campbell
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307
View more
  15 in total

Review 1.  Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells.

Authors:  Hye-Jung Kim; Harvey Cantor
Journal:  Semin Immunol       Date:  2011-12       Impact factor: 11.130

Review 2.  Regulatory T cells and immune tolerance in the intestine.

Authors:  Oliver J Harrison; Fiona M Powrie
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

3.  All-trans retinoic acid and rapamycin synergize with transforming growth factor-β1 to induce regulatory T cells but confer different migratory capacities.

Authors:  Siddharth Jhunjhunwala; Leo C Chen; Erin E Nichols; Angus W Thomson; Giorgio Raimondi; Steven R Little
Journal:  J Leukoc Biol       Date:  2013-07-29       Impact factor: 4.962

Review 4.  T-bet-/- RAG2-/- ulcerative colitis: the role of T-bet as a peacekeeper of host-commensal relationships.

Authors:  Wendy S Garrett; Laurie H Glimcher
Journal:  Cytokine       Date:  2009-08-08       Impact factor: 3.861

5.  Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.

Authors:  Ryan L Brunsing; Eric R Prossnitz
Journal:  Immunology       Date:  2011-07-02       Impact factor: 7.397

Review 6.  Once a Treg, always a Treg?

Authors:  Deepali V Sawant; Dario A A Vignali
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

Review 7.  Homeostasis and inflammation in the intestine.

Authors:  Wendy S Garrett; Jeffrey I Gordon; Laurie H Glimcher
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 8.  Cancer inflammation and regulatory T cells.

Authors:  Susan E Erdman; Theofilos Poutahidis
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 9.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

10.  Alterations in regulatory T cells induced by specific oligosaccharides improve vaccine responsiveness in mice.

Authors:  Marcel A Schijf; Joann Kerperien; Jacqueline Bastiaans; Kirsten Szklany; Jenny Meerding; Gerard Hofman; Louis Boon; Femke van Wijk; Johan Garssen; Belinda Van't Land
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.